Ney Carter Borges/LinkedIn
Apr 2, 2026, 16:08
Ney Carter Borges: Early Surgery vs Conservative Care in Asymptomatic Very Severe Aortic Stenosis
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared a post on LinkedIn:
”Early surgery vs conservative care in asymptomatic very severe aortic stenosis (10-year outcomes)
Key findings (Recovery Trial – 10-Year Follow-up)
Population:
Asymptomatic patients with very severe aortic stenosis
(AVA ≤0.75 cm², Vmax ≥4.5 m/s)
Primary Outcome (CV death or operative mortality):
- Early Surgery: 3%
- Conservative Care: 24%
- HR 0.10 (95% CI 0.02–0.43; p=0.002)
All-Cause Mortality:
- Early Surgery: 15%
- Conservative Care: 32%
- HR 0.42 (95% CI 0.21–0.86)
Heart Failure Hospitalization:
- Early Surgery: 0%
- Conservative Care: 19%
Number Needed to Treat (10 years):
- NNT ≈ 6 (CV death)
- NNT ≈ 7 (all-cause death)
Clinical interpretation
- Early intervention dramatically reduces cardiovascular mortality
- Benefit is sustained over 10 years (no curve convergence)
- Conservative strategy leads to:
- Delayed surgery
- Higher HF burden
- Increased pre-operative risk
- Key insight: ‘Waiting for symptoms may allow irreversible myocardial damage’
Practice-changing message
In carefully selected asymptomatic patients with very severe AS, early surgical AVR should be strongly considered, especially when:
- Low surgical risk
- High transvalvular velocity
- Evidence of disease progression.”

Other posts featuring Net Carter Borges on Hemostasis Today.
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
-
Jun 1, 2026, 17:00Azusa Nagao: Organizing the Symposium on Women and Bleeding Disorders at JSTH Annual Meeting
-
Jun 1, 2026, 16:57Kuljeet Kaur: Approach to Anemia – More Than Just a Low Hemoglobin